Psychodynamic therapy is evidence-based. Multiple meta-analyses, randomized controlled trials, and neuroimaging studies support its effectiveness for depression, anxiety, personality disorders, and other mental health conditions. It is not as extensively researched as cognitive behavioral therapy (CBT), which has historically received more research funding, but the evidence that does exist is strong and growing.
What the Overall Numbers Show
A meta-analysis published in JAMA examined long-term psychodynamic psychotherapy for complex mental health conditions and found a between-group effect size of 1.8. To put that in practical terms, patients who received psychodynamic therapy were, on average, better off than 96% of patients in comparison groups. In clinical research, an effect size above 0.8 is considered large. An effect size of 1.8 is exceptional, though it reflects the particular population studied: people with complex, difficult-to-treat conditions where long-term therapy has more room to demonstrate its value.
A broader look across shorter-term formats tells a more nuanced story. Research on therapy dosage suggests that roughly 50% of patients show measurable improvement by eight sessions, and about 75% improve by 26 sessions. These numbers apply across therapy types, not just psychodynamic approaches. Some researchers have argued those estimates are optimistic, noting that in real-world clinical settings, only about 20% of patients improved within an average of five sessions, and that treatment limits should extend well beyond 20 sessions for the majority of people to experience meaningful gains.
Depression and Anxiety Outcomes
For depression specifically, the evidence is substantial. In a large randomized trial of 341 adults with major depression, researchers directly compared 16 sessions of CBT to 16 sessions of short-term psychodynamic therapy. They found no significant differences between the two on any outcome measure, either at the end of treatment or at follow-up. Psychodynamic therapy was formally shown to be “noninferior” to CBT for anxiety symptoms, pain, and quality of life. This was the first study to demonstrate that psychodynamic therapy can be at least as effective as CBT for depression across multiple dimensions of patient functioning.
Studies in younger populations reinforce these findings. In one trial, 85% of adolescents receiving short-term psychodynamic therapy no longer met diagnostic criteria for depression by the end of treatment. In another study at the Anna Freud Centre, 75% of children with major depression showed reliable improvement and were free of depressive symptoms after treatment. More than half of those children remained free of any psychiatric disorder a full year after therapy ended.
Anxiety research, while smaller in scale, points in the same direction. In one trial, 60% of children receiving psychodynamic therapy had fully remitted by the end of treatment, compared to 0% in the waitlist control group.
Borderline Personality Disorder
Personality disorders are where psychodynamic approaches have some of their deepest roots, and the evidence here is solid. Two specialized psychodynamic treatments have been tested in randomized trials for borderline personality disorder: mentalization-based treatment (MBT) and transference-focused psychotherapy (TFP).
MBT, which focuses on helping people understand their own mental states and those of others, has been tested in several randomized trials. The first showed very large treatment effects compared to standard community care when delivered in a partial-hospital setting over 18 months. Those gains held at both 18-month and 5-year follow-up. An outpatient version produced similarly promising results, and a head-to-head comparison found MBT produced outcomes comparable to dialectical behavior therapy (DBT), which is widely considered the gold standard for borderline personality disorder.
TFP has shown efficacy in two randomized trials, performing similarly to DBT in one and outperforming community psychotherapy in another. It did not fare as well against schema therapy in a third trial, partly because more patients dropped out of TFP. Overall, reviews have concluded that both DBT and specialized psychodynamic therapies are superior to standard treatment for borderline personality disorder.
Gains That Continue After Therapy Ends
One of the more distinctive findings in psychodynamic research involves what happens after treatment stops. A randomized trial tracking patients over three years found that short-term psychodynamic therapy produced faster results in the first year, with 15 to 27% lower symptom scores compared to long-term psychodynamic therapy. By the second year, the two approaches were equal. But by the third year, long-term psychodynamic therapy had pulled ahead, showing 14 to 37% lower scores across measures of depression and anxiety.
Over the full three-year follow-up, patients showed a 51% reduction in depression scores, a 41% reduction in anxiety symptoms on one scale, and a 38% reduction on another. The pattern suggests that short-term approaches produce quicker relief, but longer psychodynamic therapy builds something that keeps working after sessions end. Researchers sometimes call this the “sleeper effect,” where the internal changes set in motion during therapy continue to unfold over time.
Brain Changes From Psychodynamic Treatment
Neuroimaging research has added a biological dimension to the evidence base. In one study of patients with panic disorder, brain scans before treatment showed a characteristic pattern: the brain’s fear and threat-detection centers (the amygdala and hippocampus) were overactive, while the prefrontal regions responsible for regulating those responses were underactive. After short-term psychodynamic treatment, panic symptoms improved significantly, and the brain scans showed a normalized pattern of activity between these regions.
What makes this finding particularly notable is that the neural changes looked similar to those previously documented in studies of CBT. The two therapies use very different methods, talking about different things in the room, but appear to produce comparable shifts in the brain circuits involved in emotional regulation.
Where the Evidence Stands Compared to CBT
CBT has a much larger research base, with hundreds more randomized trials across a wider range of conditions. This gap has sometimes been misread as evidence that psychodynamic therapy doesn’t work, when it more accurately reflects decades of funding priorities and the fact that CBT’s structured, manualized format is easier to study in controlled trials. Psychodynamic therapy’s emphasis on the unique therapeutic relationship and open-ended exploration makes it harder to standardize for research purposes.
Where head-to-head comparisons do exist, the two approaches tend to perform similarly. The large Dutch depression trial is the clearest example, but the pattern holds across other conditions as well. The practical takeaway is that psychodynamic therapy is a well-supported treatment option, not a lesser alternative to CBT. The best choice depends on what you’re dealing with, what resonates with you, and the specific training of the therapist available to you.